SMS Pharmaceuticals vs Nifty 50: Returns Compared
- October 12, 2026
- Posted by: Kunal Singla
- Category: Market
SMS Pharmaceuticals share price Rs 444.65 on NSE. SMS Pharmaceuticals vs Nifty 50 over 1 year: +61.90% vs -10.93%. 52-week high Rs 494.45, low Rs 270.10.
Quick Answer
SMS Pharmaceuticals vs Nifty 50 gives a mixed picture: SMS Pharmaceuticals has beaten the index in 4 of 5 time frames, and its 1-year return of +61.90% compares with -10.93% for the Nifty 50. Over three years, SMS Pharmaceuticals gained 265.37% while the Nifty 50 gained 13.77%, a gap of 251.60 percentage points in its favour. At Rs 444.65, SMS Pharmaceuticals is 10.1% below its 52-week high of Rs 494.45 and 64.6% above its 52-week low of Rs 270.10. Returns use NSE closing prices to 9 October 2026, and past performance does not indicate future results.
SMS Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. SMS Pharmaceuticals trades on the NSE under the symbol SMSPHARMA, and its 1-month return of -4.06% compares with -3.75% for the Nifty 50 over the same period.
The SMS Pharmaceuticals vs Nifty 50 comparison matters because SMS Pharmaceuticals is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up SMS Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 9 October 2026.
Also read – SIS vs Nifty 50: Share Price Performance Compared
Click Here – Get Free Investment Predictions
SMS Pharmaceuticals vs Nifty 50: Performance at a Glance
The table below sets out the SMS Pharmaceuticals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 9 October 2026.
| Time Frame | SMS Pharmaceuticals Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -4.06% | -3.75% | -0.31 pp |
| 3 Months | +10.42% | -6.97% | +17.39 pp |
| 6 Months | +6.27% | -6.36% | +12.63 pp |
| 1 Year | +61.90% | -10.93% | +72.83 pp |
| 3 Years | +265.37% | +13.77% | +251.60 pp |
On the SMS Pharmaceuticals vs Nifty 50 scorecard, SMS Pharmaceuticals has beaten the index over the latest 1-year window, returning +61.90% against -10.93% for the Nifty 50, a difference of 72.83 percentage points. The widest gap on the table is over three years, where SMS Pharmaceuticals gained 265.37% while the Nifty 50 gained 13.77%, a difference of 251.60 percentage points in favour of the stock. The direction differs over the past year: SMS Pharmaceuticals moved up while the Nifty 50 moved down.
Check the Univest Screener for live SMS Pharmaceuticals and Nifty 50 data
Latest Close and 52-Week Range: SMS Pharmaceuticals and the Nifty 50
| Instrument | Latest Close | 52-Week High | 52-Week Low | Vs 52-Week High |
|---|---|---|---|---|
| SMS Pharmaceuticals | Rs 444.65 | Rs 494.45 | Rs 270.10 | -10.1% |
| Nifty 50 | 22,520.45 | 26,373.20 | 22,179.90 | -14.6% |
SMS Pharmaceuticals closed at Rs 444.65 on 9 October 2026, which is 10.1% below its 52-week high of Rs 494.45 and 64.6% above its 52-week low of Rs 270.10. The Nifty 50 closed at 22,520.45, 14.6% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.
Why the SMS Pharmaceuticals vs Nifty 50 Gap Exists
SMS Pharmaceuticals can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: SMS Pharmaceuticals has traded between Rs 270.10 and Rs 494.45, a spread of 83.1% from low to high, against 18.9% for the Nifty 50.
Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move SMS Pharmaceuticals’s price sharply in either direction, while the Nifty 50’s return reflects the blended earnings of its constituents and is far less exposed to any single company’s news.
Download the Univest iOS App or Univest Android App to track SMS Pharmaceuticals and Nifty 50 live on the go.
SMS Pharmaceuticals vs Nifty 50: Has SMS Pharmaceuticals Beaten the Benchmark?
Yes, over the past year. SMS Pharmaceuticals returned +61.90% against -10.93% for the Nifty 50, a lead of 72.83 percentage points. Across the five time frames measured, SMS Pharmaceuticals is ahead of the index over 3 months, 6 months, 1 year and 3 years and behind it over 1 month.
Risks of the SMS Pharmaceuticals vs Nifty 50 Comparison
Point-to-point returns can mislead, and the SMS Pharmaceuticals vs Nifty 50 comparison is no exception. A different start date would shift every figure in the table above, and past performance does not indicate how either SMS Pharmaceuticals or the Nifty 50 will perform from here.
Also read – SKF India (Industrial) vs Nifty 50: Returns Compared
SMS Pharmaceuticals carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 270.10 to Rs 494.45 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.
Conclusion
SMS Pharmaceuticals vs Nifty 50 shows SMS Pharmaceuticals ahead of the index in 4 of 5 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit SMS Pharmaceuticals into a wider portfolio.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has SMS Pharmaceuticals outperformed the Nifty 50 in the last year?
Ans. Yes. SMS Pharmaceuticals returned +61.90% over the past year while the Nifty 50 returned -10.93%, based on NSE closing prices to 9 October 2026.
How does SMS Pharmaceuticals vs Nifty 50 look over 3 years?
Ans. Over three years SMS Pharmaceuticals has returned +265.37% compared with the Nifty 50’s +13.77%, so in the SMS Pharmaceuticals vs Nifty 50 comparison the stock has been ahead over this horizon.
What is the SMS Pharmaceuticals share price today compared to Nifty 50?
Ans. SMS Pharmaceuticals share price closed at Rs 444.65 on NSE on 9 October 2026, while the Nifty 50 closed at 22,520.45 in the same session.
What is the 52-week high and low of SMS Pharmaceuticals?
Ans. SMS Pharmaceuticals’s 52-week high is Rs 494.45 and its 52-week low is Rs 270.10, based on NSE data. The latest close of Rs 444.65 is 10.1% below the high.
Why does SMS Pharmaceuticals show bigger price swings than the Nifty 50?
Ans. SMS Pharmaceuticals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks SMS Pharmaceuticals has traded in a 83.1% low-to-high range against 18.9% for the index, a key reason the SMS Pharmaceuticals vs Nifty 50 return gap varies across time frames.
Is SMS Pharmaceuticals a good long-term investment compared to a Nifty 50 index fund?
Ans. SMS Pharmaceuticals’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the SMS Pharmaceuticals vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
